Flamingo Therapeutics to Present at BioCapital Europe 2022
LEUVEN, Belgium, March 7, 2022 /PRNewswire/ -- Flamingo Therapeutics., a biotechnology company pioneering RNA-targeting therapies in oncology, today announced that Mike Garrett, Chief Executive Officer, will present at the BioCapital Europe 2022 meeting on March 10th, 2022 at 5pm CET/11am ET. The Flamingo management team will also participate in one-on-one meetings with investors during the conference. BioCapital Europe will be taking place in person at Hotel Sofitel Legend The Grand Amsterdam.